Xenobiotica · 1996 · 24 citations · 13 references
PharmacyPharmacokineticsPharmacologyBioavailabilityComparative PharmacologyRenal PharmacokineticsDrug DispositionRenal Drug AbsorptionRenal Drug ClearanceRenal Drug DistributionRenal EliminationRenal PharmacologyBiliary Elimination KineticsInhibitor RetentionPlasma Renin ActivityRadioligand PharmacokineticsRenal Drug Excretion
1. Whole-body autoradiography was used to compare the distribution of remikiren in the squirrel monkey, in which the compound is a potent inhibitor of renin, with the rat and the guinea-pig in which it is less active. 2. Following intravenous administration, drug-related material was rapidly and extensively taken up by the tissues of all three species. Consistent with rapid biliary elimination, high levels of radioactivity were found in the bile duct/gall bladder/intestinal contents. Of the remaining organs, the kidney consistently showed the highest concentrations of drug-related material. 3. Radio-hplc analysis of the kidney samples demonstrated that the majority of the retained material was present as intact remikiren, even at 24 h after administration. A similar degree of retention by the kidney was also found after oral dosing. 4. Uptake of remikiren by the kidney may act as a reservoir for the drug, resulting in the prolonged duration of pharmacological activity, which, despite the high plasma clearance of the drug, has previously been observed in primates.
13
Angiotensin I converting enzyme.
Ervin G. Erdös · Circulation Research · 1975 · 561 citations
Ro 42-5892 is a potent orally active renin inhibitor in primates.
Walter Fischli, Jean‐Paul Clozel, K el Amrani et al. · Hypertension · 1991 · 101 citations
Characterization of pure human renal renin. Evidence for a subunit structure.
Y S, Tatsuo Shinagawa, Helen Tam et al. · Journal of Biological Chemistry · 1987 · 63 citations · Full text